Interesting to see that Capricor (CAPR) with a very second rate treatment for inflammation for DMD is currently up to US$150m market cap.
Their results do not come t near ours and they do not have the biological and MOA data that ANP also has.
Great to see interest in the space though.
James Garner AKA JG, page-102
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.008(8.25%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 11.0¢ | 9.8¢ | $341.0K | 3.273M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 99186 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 611651 | 9 |
View Market Depth
| Last trade - 14.46pm 17/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |